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SUMMARY
Osteoporosis causes micro-degradations and jaw-bone reduction. Initial 
positive turnover and bone recover should make hasten by local medication 
of osteoporotic jaws. The aim of this study was to present improvement of jaw 
pattern by local application of calcitonin and calcium throughout prosthetic 
treatment of selected osteoporotic patients. Patients undergoing study were 
osteoporotic and toothless (9 males and 27 females), with no malignancy. 
Non-osteoporotic complete denture wearers, 7 men and 7 women were con-
trols. DPX-L (Lunar) was used in detection of skeletal degradations. Pano-
ramic radiographs (Orthopantomograph 10, Siemens) and digital densito-
meter DT II 05 (England) were used in the analysis of bone density. T-results 
indicated systemic osteoporosis.
After application of calcium and calcitonin in solutions, moderate 
increase of density (p<0.05) was verified, compensating up to 3% of total 
mandibular loss. The second section of results was restorative effect of pros-
thetic treatment of osteoporotic patients. In this study, osteoporosis affected 
women patients earlier than men.
Regardless the necessity of careful selecting of patients for this kind of 
treatment, calcitonin and calcium in solutions should be considered as the 
priority of local therapy in osteoporotic toothless patients, providing positive 
bone remodelling, as well as success at the second level of therapy - posi-
tioning of dentures. 
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Osteoporosis is the most common type of bone disease 
over the lifetime, affecting human bones indiscriminately 
and haphazardly. A variety of micro-structural osteoporotic 
degradations and macroscopic resorption of oral bones 
was very well evidenced3,4,6,7,10-12,14,17. Moreover, it was 
reported that osteoporosis of human oral bones damaged 
not only bone support of remaining teeth, but induced 
reductions of denture retention and stability, too17. Analysis 
of bone layer’s appearance on panoramic radiographs is the 
valuable method of assessing bone changes in any of bone 
turnovers1,3,7,14,20.
Diet and nutritional factors are of extreme significance 
for prevention of osteoporosis, but minor results should 
be expected regarding initiation of positive remodelling 
of fragile osteoporotic bone8,10. Considering assorted 
literature data on multiple drug therapy and possibilities of 
systemic medication, it could be of particular importance 
to focus dependable medical oral treatment approaches 
in osteoporotic affections4,16,17,19. Calcitonin accelerates 
influx of calcium, improving bone density and mineral 
content of bone, either in local, or systemic level7-9,10,14. 
This positive remodelling of osteoporotic bones could 
be finally reached in mandibular bone, as well as in 
other human bones2,5,7-9,15-19. The aim of this study is to 
present improvement of mandibular-bone pattern by local 
application of calcitonin and calcium throughout prosthetic 
treatment of selected osteoporotic patients.
Material and Method
The experimental group comprised 9 men (aged 
64-90; mean age 87 years), and 29 women (aged 56-81; 
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mean age 58 years), edentulous and osteoporotic, with no 
malignant diseases (Fig. 1). 7 toothless men and 7 toothless 
women patients were controls (Fig. 2). Patients were 
selected concerning dental-oral history, questionnaire (age, 
probable treatments of osteoporosis in the past, history of 
fractures, menopausal periods, calcium and microelements 
of plasma-blood, additional Pyrilinx-D and Prolagen-C 
tests), oral examination (bone consistency and resorptions) 
and skeletal density. 3 women from the experimental 
group (on estrogens) and 3 osteoporotic men patients were 
on systemic therapy of osteoporosis after hospitalization. 
DPX-L analysis (Lunar, U.S.A.) and T-results of patients 
were provided.
Figure 1. Oral status of osteoporotic patient of the experimental group 
before treatment
Figure 3. Panoramic radiograph of osteoporotic jaws of the patient of 
the experimental group
Figure 4. Grid positioned onto regions of particular interest of the 
osteoporotic mandible of the patient of the experimental group, prior to 
densitometric assessment
Figure 5. Determined regions of interest - Pr, M1r, M2r, Pl, M1l,M2l
Figure 6. Local application of anaesthetic on mucosal surface before 
injecting medicament – solution of calcitonin with calcium
Figure 2. Non-resorbed jaw of the patient of the control group
Panoramic radiographs of each patient (Orthopantomo-
graph 10; serial no. 01492; Siemens, Germany),  focused 
osteoporotic remodelling of jaws (Figs. 3-5).
Calcitonin (Miacalcic, Novartis, Switzerland; 
Calcitonin Huber, Galenika AD, Serbia), and calcium 
gluconate (Sterop, Brussles, Belgium), or calcium 
glubionat (Calcium-Sandoz amp., Switzerland) were used 
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The results of medication of supporting bone tissues 
primarily affected by osteoporosis were favourable in 
this study. Increase of density of mandibular segments 
after the therapy was significant, particularly for Pr and 
Pl segments (p < 0.01). Following application of calcium 
and calcitonin in solutions, moderate increase of jaw-bone 
density was observed (p < 0.05), compensating up to 3% 
of total mandibular-bone loss (Tabs. 1 – 3). 
The second section of results were restorative 
effects of oral-prosthodontic treatment of the selected 
osteoporotic patients. Edentulous osteoporotic patients 
were rehabilitated in the observation period (Fig. 9). 
locally to improve bone pattern in osteoporotic patients. 
Up to 1.5 ml of calcitonin and calcium solution (1:2) was 
injected submucously onto mandibular bone surfaces 
(Figs. 6-8). Complete dentures were fabricated for each of 
the patient of the experimental group (Fig. 9). 
Digital densitometer DT II 05 (England, UK) was 
used in the analysis of mandibular segments’ bone density 
at panoramic radiographs after the therapy (Fig. 10)10,15. 
Results
T results indicated systemic osteoporosis. The 
numerical values of T result ranged from -2.4 to -2.6 for 
male patients, and -2.5 to -2.6 for female patients.
Figure 7. Submucous injection of therapeutic solution of calcitonin and 
ion calcium onto  buccal bone surface of osteoporotic mandible of the 
patient of the experimental group
Figure 10. Panoramic radiograph of the patient after local increase of 
density of the edentulous mandible
Figure 8. Injection of therapeutic solution of calcitonin and calcium to 
the right side of the buccal mandibular osteoporotic surface
Figure 9. Complete dentures restored all of the supporting tissues and 
occlusion - dentures in the mouth , after necessary increments of bone 
density of the lower jaw
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Table 1. Increase of mandibular density of the experimental 
group and bone pattern improve






Pr 0.8% ± 0.8
Pl 0.85% ± 0.6
M1r 0.84% ± 0.1
M1l 0.83% ± 0.2
M2r 0.84% ± 0.4
M2l 0.84% ± 0.3 Pr+Pl+M1r+M1l +M2r+M2l ≅ 3% 
Table 2. Statistical significance and differences of numerical 
values of mandibular density between the control and the 
experimental group
 Differences of numerical
 values of optical density
Segment regarding the baseline of the 
 control group and the baseline of 
 experimental group
Pr P < 0.01
Pl P < 0.01
M1r P < 0.05
M1l P < 0.05
M2r P < 0.05















In dental literature there were few reports on the 
treatment and local medication of jaw-bones. Based 
on certain medical studies and monographs, there 
were 2 major approaches to the treatment. The first 
treatment approach has been related to application of 
bisfosfonates4,7,10,17-19. The second approach considered 
calcitonin as the primary accelerator of calcium’s influx to 
the bone4,10,17-19. Additionally, there were considerations of 
application of calcitonin, as well as bisfosfonates, locally 
to jaw-bones and denture-supporting areas2,5,7,9,10,15,16. 
Considering various facts on bisfosfonates - studies were 
mainly conducted on patients undergoing systemic therapy 
with bisfosfonates, and there is only a few of studies on 
application of bisfosfonates on the local (oral) level, 
as well as the fact that certain interruptions of immune 
response were described as possible complication of the 
extended bisfosfonate usage - it seemed reasonable to 
apply calcitonin and calcium in solutions locally, in vivo, 
to osteoporotic jaws2,4,5,18,19. The effects of treatment 
is difficult to compare to different calcitonin effects as 
they were acquired in experimental animals, but not in 
humans9,10,15,16. 
Calcitonin was described as the substance strongly 
regulating influx of calcium4. Calcium influx should 
have been provided by mobilization of “free” calcium 
ion from blood plasma, as well as by exchanging calcium 
ion of the medicament (calcium gluconate or calcium 
glubionas)4,10. Respecting specificity of blood flow to 
the human mandible, and the fact that mandible usually 
is not supplied by plenty of blood, it seemed reasonable 
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to assume that calcium ions from blood vessels do not 
provide a needed intensity of calcium influx towards 
osteoporotic degradations7,11. Furthermore, additional 
sources of calcium ion, directed towards credible local 
storage near enough to the mandible bone, should have 
beneficial effect.
There is no enough evidence in dental literature on 
local application of calcitonin and calcium into hard 
oral tissues. Because of that, it should be not possible to 
compare the results of the present study with results of 
credible studies regarding the percentage of calcium and 
calcitonin in train solution7,9,10,15. Moreover, in this 
point of view, it should not be possible to adjoin if the 
increment of concentration of calcium has to be applied 
to the surface of edentulous ridge, or the concentration 
of calcium in solution has to be ultimately changed (or 
decreased) in cases of persistence of roots of the remaining 
teeth.
Certainly, on the basis of the results of this study, it 
may be stated that calcitonin in calcium solution should 
have been applied to edentulous ridge prior to positioning 
of the denture onto supporting tissues, that is delivery of 
prosthesis. More precisely, it should be injected towards 
bone support in the initial steps of denture fabrication, i.e. 
taking preliminary impression, and previous to functional 
impression, or even in the procedure of determining jaw 
relations with occlusal rims.
Calcitonin and calcium liquid is not a „supernatural 
drop“ for instant recover of osteoporotic bone layers. 
However, careful selection of patients, as well as repeated 
application of calcitonin and calcium in solutions to bone 
layers, may significantly improve oral bone condition 
and ability to accept prosthetic restoration on denture-
supporting areas.
The local application of calcitonin with calcium 
could be repeated, if necessary. However, there must be 
the necessity of careful selecting the patients, because of 
the fact that application of calcium should not be indicated 
for patients with heart disease, kidney disease or serious 
blood problems. Also, patients with malignant diseases 
must not be included in the local therapy of osteoporotic 
oral bones. In spite of the limitations, local application of 
calcitonin and calcium should be the absolute prerequisite 
of organizing positive bone remodelling and turnover 
of segments of jaws. Thus, these segments should be 
prepared for better acceptance of denture surface.
Edentulous osteoporotic mandibular bone should 
ultimately be the first of oral bones for application of 
calcitonin-ion calcium solution. Additionally, respecting 
levels of the concentration of the applied calcium ion, 
the osteoporotic maxillary bone could be treated with the 
solution of the same kind, in the prolonged period of time.
It seems that osteoporosis of the mandible affects 
women earlier than men. Also, osteoporosis was more 
frequent in women. Usage of calcitonin and calcium in 
solutions for osteoporotic toothless patients should be 
considered as the priority of local oral treatment. In spite 
of the limited value of local application, calcitonin and 
calcium should be the absolute prerequisite for organizing 
positive bone remodelling and turnover of segments 
of jaws which should be, this way, prepared for better 
acceptance of denture surface. Regardless the absence of 
macroscopic evidence of bone tissue regeneration, local 
application of calcitonin with calcium could be crucial for 
the success at the first level of the treatment (turnover and 
positive bone remodelling), as well as for the second level 
of treatment (fabrication and positioning of dentures). 
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